Events
WEBINAR: Noninvasive imaging approach to quantifying NASH and assessing emerging therapeutics
10
May
May
WEBINAR INVITATION
Date: 16th November 2021, Tuesday
Time: 5.00 PM Singapore
Venue: Webinar
Nonalcoholic fatty liver disease (NAFLD) affects nearly 25% of the population – and of those, around 25% progress to nonalcoholic steatohepatitis (NASH). Despite an increase in prevalence, however, there remains no FDA-approved treatment for NASH.
This webinar explores a noninvasive approach to better understand NASH disease pathology for earlier diagnosis and new therapeutic development, and explores emerging therapeutics now in clinical trials.
To learn more, visit the webinar registration page for more information.
